$34.8 Million is the total value of Ulys, L.L.C.'s 2 reported holdings in Q2 2015. The portfolio turnover from Q1 2015 to Q2 2015 was 200.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| LXRX | New | LEXICON PHARMACEUTICALS INC | $34,786,000 | – | 4,321,214 | +100.0% | 99.98% | – |
| CERE | New | CERES INC | $8,000 | – | 3,891 | +100.0% | 0.02% | – |
| CERE | Exit | CERES INC | $0 | – | -31,131 | -100.0% | -0.04% | – |
| LXRX | Exit | LEXICON PHARMACEUTICALS INC | $0 | – | -30,248,505 | -100.0% | -99.96% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-08-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LEXICON PHARMACEUTICALS INC | 24 | Q1 2021 | 100.0% |
| LEXICON PHARMACEUTICALS INC | 8 | Q1 2015 | 100.0% |
| CERES INC | 8 | Q1 2015 | 0.2% |
| CERES INC | 5 | Q2 2016 | 0.0% |
View Ulys, L.L.C.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2022-08-09 |
| 4 | 2022-08-01 |
| 13F-HR | 2021-05-14 |
| 13F-HR | 2021-02-11 |
| 13F-HR | 2020-11-13 |
| 13F-HR | 2020-08-14 |
| 13F-HR | 2020-05-14 |
| 13F-HR | 2020-02-13 |
| 13F-HR | 2019-11-14 |
| 13F-HR | 2019-08-09 |
View Ulys, L.L.C.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.